Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company's Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon
Businesswire·2025-09-22 10:00HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, "Yunqi Capital†), an investment management firm and 5.1% shareholder of STAAR Surgical Company ("STAAR†) (NASDAQ:STAA), today announced its opposition to the Company's proposed sale to Alcon Inc. (SIX/NYSE:ALC) on the terms announced on August 5, 2025. Yunqi Capital released the following open letter to fellow STAAR shareholders explaining why it opposes the transaction: September 22, 2025. ...